Physician profile
Jonathan Hartman
NPI 1760560478
$5,090.87
in general payments reported to CMS, 2019-2025
8 companies · $176 in 2025
The $176 reported for 2025 was less than what a typical Neuroradiology provider received nationally (typical 2025 total: $278).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,975 · 2022: $229 · 2023: $1,420 · 2024: $290 · 2025: $176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,535 · Travel and Lodging: $352.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,534.85 |
| Travel and Lodging | $351.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shape Memory Medical INC. | $2,975.00 | 2019 | |
| Janssen Research & Development, LLC | $641.54 | 2023 | |
| Stryker Corporation | $438.43 | 2022-2025 | Surpass Evolve, Target |
| Medtronic, INC. | $383.81 | 2023 | Solitaire X |
| Penumbra, INC. | $269.99 | 2023 | Red 72 |
| Rapid Medical LTD | $142.00 | 2024 | Comaneci 17, Tigertriever 17 Revascularization Device |
| Microvention, INC. | $124.99 | 2023 | Web Aneurysm Embolization System |
| Depuy Synthes Sales INC. | $115.11 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$2,488,504.54 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Hartman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.